ERIN FLOYD: Open Payments
NPI 1508127911 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 51 payments from 16 companies in 2025. Trend: 2023 $1,044 · 2024 $820 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $180 |
| AstraZeneca Pharmaceuticals LP | 9 | $143 |
| GlaxoSmithKline, LLC. | 6 | $106 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $103 |
| Dexcom, Inc. | 3 | $67 |
| Exact Sciences Corporation | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| PFIZER INC. | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $29 |
Products named: TRELEGY ELLIPTA, XIFAXAN, Wegovy, Dexcom G6 Transmitter, Cologuard Collection Kit, JARDIANCE, ELIQUIS, Rybelsus.
Industry payments across SC — which companies pay providers there.
